Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Christine Lu, Ph.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Gavan SP, Lu CY, Payne K. Assessing the Joint Value of Genomic-Based Diagnostic Tests and Gene Therapies. J Pers Med. 2019 May 21; 9(2). PMID: 31117188.
    Citations:    
  2. Karas L, Lu CY, Agrawal PB, Asgari MM. The Impact of the Orphan Drug Act on FDA-Approved Therapies for Rare Skin Diseases and Skin-Related Cancers. J Am Acad Dermatol. 2019 May 16. PMID: 31103566.
    Citations:    
  3. Hendricks-Sturrup RM, Lu CY. Direct-to-Consumer Genetic Testing Data Privacy: Key Concerns and Recommendations Based on Consumer Perspectives. J Pers Med. 2019 May 09; 9(2). PMID: 31075859.
    Citations:    
  4. Hendricks-Sturrup RM, Prince AER, Lu CY. Direct-to-Consumer Genetic Testing and Potential Loopholes in Protecting Consumer Privacy and Nondiscrimination. JAMA. 2019 Apr 18. PMID: 30998825.
    Citations:    
  5. Stewart CC, Lu CY, Yoon TK, Coleman KJ, Crawford PM, Lakoma MD, Simon GE. Impact of ICD-10-CM Transition on Mental Health Diagnoses Recording. EGEMS (Wash DC). 2019 Apr 12; 7(1):14. PMID: 31065557.
    Citations:    
  6. Hendricks-Sturrup RM, Lu CY. Understanding Implementation Challenges to Genetic Testing for Familial Hypercholesterolemia in the United States. J Pers Med. 2019 Feb 01; 9(1). PMID: 30717118.
    Citations:    
  7. Owen-Smith AA, Ahmedani BK, Peterson E, Simon GE, Rossom RC, Lynch FL, Lu CY, Waitzfelder BE, Beck A, DeBar LL, Sanon V, Maaz Y, Khan S, Miller-Matero LR, Prabhakar D, Frank C, Drake CL, Braciszewski JM. The Mediating Effect of Sleep Disturbance on the Relationship Between Nonmalignant Chronic Pain and Suicide Death. Pain Pract. 2019 04; 19(4):382-389. PMID: 30462885.
    Citations:    Fields:    
  8. Wharam JF, Lu CY, Zhang F, Callahan M, Xu X, Wallace J, Soumerai S, Ross-Degnan D, Newhouse JP. High-Deductible Insurance and Delay in Care for the Macrovascular Complications of Diabetes. Ann Intern Med. 2018 Dec 18; 169(12):845-854. PMID: 30458499.
    Citations:    Fields:    
  9. Hsu JC, Su YC, Tang BY, Lu CY. Use of assisted reproductive technologies before and after the Artificial Reproduction Act in Taiwan. PLoS One. 2018; 13(11):e0206208. PMID: 30383814.
    Citations:    Fields:    
  10. Rahm AK, Cragun D, Hunter JE, Epstein MM, Lowery J, Lu CY, Pawloski PA, Sharaf RN, Liang SY, Burnett-Hartman AN, Gudgeon JM, Hao J, Snyder S, Gogoi R, Ladd I, Williams MS. Implementing universal Lynch syndrome screening (IMPULSS): protocol for a multi-site study to identify strategies to implement, adapt, and sustain genomic medicine programs in different organizational contexts. BMC Health Serv Res. 2018 Oct 30; 18(1):824. PMID: 30376847.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  11. Wu AC, Mazor KM, Ceccarelli R, Loomer S, Lu CY. The Implementation Process for Pharmacogenomic Testing for Cancer-Targeted Therapies. J Pers Med. 2018 Oct 01; 8(4). PMID: 30275409.
    Citations:    
  12. Hsu JC, Wu HC, Feng WC, Chou CH, Lai EC, Lu CY. Disease and economic burden for rare diseases in Taiwan: A longitudinal study using Taiwan's National Health Insurance Research Database. PLoS One. 2018; 13(9):e0204206. PMID: 30240449.
    Citations:    Fields:    
  13. Smith DH, Shetterly S, Flory J, Haynes K, Lu CY, Gagne JJ, Herrinton L, Nyirenda C, Patorno E, Shoaibi A, Raebel MA. Diagnosis-based cohort augmentation using laboratory results data: The case of chronic kidney disease. Pharmacoepidemiol Drug Saf. 2018 08; 27(8):872-877. PMID: 29932281.
    Citations:    Fields:    
  14. Lu CY, Soumerai SB. Comment on 'Measuring the impact of medicines regulatory interventions - systematic review and methodological considerations' by Goedecke et al. Br J Clin Pharmacol. 2018 Sep; 84(9):2167-2168. PMID: 29933525.
    Citations: 1     Fields:    
  15. Leopold C, Wagner AK, Zhang F, Lu CY, Earle CC, Nekhlyudov L, Ross-Degnan D, Wharam JF. Total and out-of-pocket expenditures among women with metastatic breast cancer in low-deductible versus high-deductible health plans. Breast Cancer Res Treat. 2018 Sep; 171(2):449-459. PMID: 29855813.
    Citations:    Fields:    
  16. Lu CY, Loomer S, Ceccarelli R, Mazor KM, Sabin J, Clayton EW, Ginsburg GS, Wu AC. Insurance Coverage Policies for Pharmacogenomic and Multi-Gene Testing for Cancer. J Pers Med. 2018 May 16; 8(2). PMID: 29772692.
    Citations:    
  17. Lu CY, Zhang F, Wagner AK, Nekhlyudov L, Earle CC, Callahan M, LeCates R, Xu X, Ross-Degnan D, Wharam JF. Impact of high-deductible insurance on adjuvant hormonal therapy use in breast cancer. Breast Cancer Res Treat. 2018 Aug; 171(1):235-242. PMID: 29754304.
    Citations:    Fields:    
  18. Daniels B, Kiely BE, Lord SJ, Houssami N, Lu CY, Ward RL, Pearson SA. Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016). Breast Cancer Res Treat. 2018 Aug; 171(1):151-159. PMID: 29736743.
    Citations:    Fields:    
  19. Lu CY, Simon G, Soumerai SB. Counter-Point: Staying Honest When Policy Changes Backfire. Med Care. 2018 05; 56(5):384-390. PMID: 29634631.
    Citations: 1     Fields:    Translation:Humans
  20. Lu CY, Penfold RB, Toh S, Sturtevant JL, Madden JM, Simon G, Ahmedani BK, Clarke G, Coleman KJ, Copeland LA, Daida YG, Davis RL, Hunkeler EM, Owen-Smith A, Raebel MA, Rossom R, Soumerai SB, Kulldorff M. Near Real-time Surveillance for Consequences of Health Policies Using Sequential Analysis. Med Care. 2018 05; 56(5):365-372. PMID: 29634627.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  21. Lu CY, Simon G, Soumerai SB, Kulldorff M. Counter-Point: Early Warning Systems Are Imperfect, but Essential. Med Care. 2018 05; 56(5):382-383. PMID: 29634630.
    Citations:    Fields:    Translation:Animals
  22. Christensen KD, Vassy JL, Phillips KA, Blout CL, Azzariti DR, Lu CY, Robinson JO, Lee K, Douglas MP, Yeh JM, Machini K, Stout NK, Rehm HL, McGuire AL, Green RC, Dukhovny D. Short-term costs of integrating whole-genome sequencing into primary care and cardiology settings: a pilot randomized trial. Genet Med. 2018 12; 20(12):1544-1553. PMID: 29565423.
    Citations: 1     Fields:    
  23. Wharam JF, Zhang F, Lu CY, Wagner AK, Nekhlyudov L, Earle CC, Soumerai SB, Ross-Degnan D. Breast Cancer Diagnosis and Treatment After High-Deductible Insurance Enrollment. J Clin Oncol. 2018 Apr 10; 36(11):1121-1127. PMID: 29489428.
    Citations: 2     Fields:    
  24. Boggs JM, Beck A, Hubley S, Peterson EL, Hu Y, Williams LK, Prabhakar D, Rossom RC, Lynch FL, Lu CY, Waitzfelder BE, Owen-Smith AA, Simon GE, Ahmedani BK. General Medical, Mental Health, and Demographic Risk Factors Associated With Suicide by Firearm Compared With Other Means. Psychiatr Serv. 2018 06 01; 69(6):677-684. PMID: 29446332.
    Citations:    Fields:    
  25. Wharam JF, Zhang F, Eggleston EM, Lu CY, Soumerai SB, Ross-Degnan D. Effect of High-Deductible Insurance on High-Acuity Outcomes in Diabetes: A Natural Experiment for Translation in Diabetes (NEXT-D) Study. Diabetes Care. 2018 05; 41(5):940-948. PMID: 29382660.
    Citations: 1     Fields:    Translation:Humans
  26. Daniels B, Kiely BE, Lord SJ, Houssami N, Lu CY, Ward RL, Pearson SA. Trastuzumab for metastatic breast cancer: Real world outcomes from an Australian whole-of-population cohort (2001-2016). Breast. 2018 Apr; 38:7-13. PMID: 29172171.
    Citations:    Fields:    Translation:Humans
  27. Wu AC, Mazor KM, Ceccarelli R, Loomer S, Lu CY. Access to Guideline-Recommended Pharmacogenomic Tests for Cancer Treatments: Experience of Providers and Patients. J Pers Med. 2017 Nov 15; 7(4). PMID: 29140263.
    Citations: 1     
  28. Lopez Bernal JA, Lu CY, Gasparrini A, Cummins S, Wharam JF, Soumerai SB. Association between the 2012 Health and Social Care Act and specialist visits and hospitalisations in England: A controlled interrupted time series analysis. PLoS Med. 2017 11; 14(11):e1002427. PMID: 29135978.
    Citations:    Fields:    Translation:Humans
  29. Daniels B, Kiely BE, Houssami N, Lord SJ, Dobbins T, Lu CY, Ward RL, Pearson SA. Survival outcomes for Australian women receiving trastuzumab for HER2-positive metastatic breast cancer following (neo)adjuvant trastuzumab: a national population-based observational study (2006-2014). Br J Cancer. 2018 02 06; 118(3):441-447. PMID: 29136405.
    Citations:    Fields:    
  30. Lu CY, Zhang F, Golonski N, Lupton C, Jeffrey P, Wagner AK. State Medicaid Reimbursement for Medications for Chronic Hepatitis C Infection from 2012 through 2015. Value Health. 2018 06; 21(6):692-697. PMID: 29909874.
    Citations:    Fields:    Translation:Humans
  31. Lu CY, Williams MS, Ginsburg GS, Toh S, Brown JS, Khoury MJ. A proposed approach to accelerate evidence generation for genomic-based technologies in the context of a learning health system. Genet Med. 2018 Apr; 20(4):390-396. PMID: 28796238.
    Citations: 1     Fields:    Translation:Humans
  32. Prabhakar D, Peterson EL, Hu Y, Rossom RC, Lynch FL, Lu CY, Waitzfelder BE, Owen-Smith AA, Williams LK, Beck A, Simon GE, Ahmedani BK. Dermatologic Conditions and Risk of Suicide: A Case-Control Study. Psychosomatics. 2018 Jan - Feb; 59(1):58-61. PMID: 28890116.
    Citations:    Fields:    
  33. Hsu JC, Chang SM, Lu CY. Geographic Variations and Time Trends in Cancer Treatments in Taiwan. BMC Public Health. 2017 08 02; 18(1):89. PMID: 28768504.
    Citations:    Fields:    Translation:Humans
  34. Adams AS, Madden JM, Zhang F, Lu CY, Ross-Degnan D, Lee A, Soumerai SB, Gilden D, Chawla N, Griggs JJ. Effects of Transitioning to Medicare Part D on Access to Drugs for Medical Conditions among Dual Enrollees with Cancer. Value Health. 2017 12; 20(10):1345-1354. PMID: 29241894.
    Citations:    Fields:    Translation:Humans
  35. Ahmedani BK, Peterson EL, Hu Y, Rossom RC, Lynch F, Lu CY, Waitzfelder BE, Owen-Smith AA, Hubley S, Prabhakar D, Williams LK, Zeld N, Mutter E, Beck A, Tolsma D, Simon GE. Major Physical Health Conditions and Risk of Suicide. Am J Prev Med. 2017 Sep; 53(3):308-315. PMID: 28619532.
    Citations: 3     Fields:    Translation:Humans
  36. Hsieh HC, Hsu JC, Lu CY. 10-year trends in statin utilization in Taiwan: a retrospective study using Taiwan's National Health Insurance Research Database. BMJ Open. 2017 05 17; 7(5):e014150. PMID: 28515189.
    Citations: 2     Fields:    Translation:Humans
  37. Wharam JF, Zhang F, Eggleston EM, Lu CY, Soumerai S, Ross-Degnan D. Diabetes Outpatient Care and Acute Complications Before and After High-Deductible Insurance Enrollment: A Natural Experiment for Translation in Diabetes (NEXT-D) Study. JAMA Intern Med. 2017 03 01; 177(3):358-368. PMID: 28097328.
    Citations: 7     Fields:    Translation:Humans
  38. Daniels B, Lord SJ, Kiely BE, Houssami N, Haywood P, Lu CY, Ward RL, Pearson SA. Use and outcomes of targeted therapies in early and metastatic HER2-positive breast cancer in Australia: protocol detailing observations in a whole of population cohort. BMJ Open. 2017 01 24; 7(1):e014439. PMID: 28119394.
    Citations: 1     Fields:    Translation:Humans
  39. Patorno E, Gagne JJ, Lu CY, Haynes K, Sterrett AT, Roy J, Wang X, Raebel MA. The Role of Hemoglobin Laboratory Test Results for the Detection of Upper Gastrointestinal Bleeding Outcomes Resulting from the Use of Medications in Observational Studies. Drug Saf. 2017 01; 40(1):91-100. PMID: 27848201.
    Citations:    Fields:    Translation:HumansPHPublic Health
  40. Hsu JC, Hsieh CL, Lu CY. Trend and geographic analysis of the prevalence of dengue in Taiwan, 2010-2015. Int J Infect Dis. 2017 Jan; 54:43-49. PMID: 27865829.
    Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
  41. Leopold C, Wagner AK, Zhang F, Lu CY, Earle C, Nekhlyudov L, Ross-Degnan D, Wharam JF. Erratum to: Racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer. Breast Cancer Res Treat. 2016 11; 160(2):385. PMID: 27696008.
    Citations:    Fields:    
  42. Tan EC, Bell JS, Lu CY, Toh S. National Trends in Outpatient Antihypertensive Prescribing in People with Dementia in the United States. J Alzheimers Dis. 2016 10 18; 54(4):1425-1435. PMID: 27589531.
    Citations:    Fields:    Translation:Humans
  43. Leopold C, Wagner AK, Zhang F, Lu CY, Earle C, Nekhlyudov L, Ross-Degnan D, Wharam JF. Racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer. Breast Cancer Res Treat. 2016 07; 158(2):333-40. PMID: 27342456.
    Citations: 2     Fields:    Translation:Humans
  44. Hsu JC, Lu CY. Longitudinal trends in use and costs of targeted therapies for common cancers in Taiwan: a retrospective observational study. BMJ Open. 2016 06 06; 6(6):e011322. PMID: 27266775.
    Citations: 2     Fields:    Translation:Humans
  45. Hsu JC, Gonzalez-Gonzalez LA, Lu VH, Lu CY. Longitudinal trends in use of targeted therapies for treatment of malignant neoplasms of the eye: a population-based study in Taiwan. BMJ Open. 2016 05 27; 6(5):e010706. PMID: 27235298.
    Citations: 1     Fields:    Translation:Humans
  46. Raebel MA, Shetterly S, Lu CY, Flory J, Gagne JJ, Harrell FE, Haynes K, Herrinton LJ, Patorno E, Popovic J, Selvan M, Shoaibi A, Wang X, Roy J. Methods for using clinical laboratory test results as baseline confounders in multi-site observational database studies when missing data are expected. Pharmacoepidemiol Drug Saf. 2016 07; 25(7):798-814. PMID: 27146273.
    Citations:    Fields:    Translation:Humans
  47. Coleman KJ, Stewart C, Waitzfelder BE, Zeber JE, Morales LS, Ahmed AT, Ahmedani BK, Beck A, Copeland LA, Cummings JR, Hunkeler EM, Lindberg NM, Lynch F, Lu CY, Owen-Smith AA, Trinacty CM, Whitebird RR, Simon GE. Racial-Ethnic Differences in Psychiatric Diagnoses and Treatment Across 11 Health Care Systems in the Mental Health Research Network. Psychiatr Serv. 2016 07 01; 67(7):749-57. PMID: 27079987.
    Citations: 5     Fields:    Translation:Humans
  48. Madden JM, Lakoma MD, Rusinak D, Lu CY, Soumerai SB. Missing clinical and behavioral health data in a large electronic health record (EHR) system. J Am Med Inform Assoc. 2016 11; 23(6):1143-1149. PMID: 27079506.
    Citations: 7     Fields:    Translation:Humans
  49. Sruamsiri R, Wagner AK, Ross-Degnan D, Lu CY, Dhippayom T, Ngorsuraches S, Chaiyakunapruk N. Expanding access to high-cost medicines through the E2 access program in Thailand: effects on utilisation, health outcomes and cost using an interrupted time-series analysis. BMJ Open. 2016 Mar 17; 6(3):e008671. PMID: 26988346.
    Citations: 1     Fields:    Translation:Humans
  50. Lu CY. Economic evaluation of whole-genome sequencing in healthy individuals: what can we learn from CEAs of whole-body CT screening? Genet Med. 2016 Jan; 18(1):103-4. PMID: 26633543.
    Citations: 1     Fields:    Translation:Humans
  51. Gammie T, Lu CY, Babar ZU. Access to Orphan Drugs: A Comprehensive Review of Legislations, Regulations and Policies in 35 Countries. PLoS One. 2015; 10(10):e0140002. PMID: 26451948.
    Citations: 20     Fields:    Translation:Humans
  52. Hsu JC, Cheng CL, Ross-Degnan D, Wagner AK, Zhang F, Kao Yang YH, Liu LL, Tai HY, Chen KH, Yang PW, Lu CY. Effects of safety warnings and risk management plan for Thiazolidinediones in Taiwan. Pharmacoepidemiol Drug Saf. 2015 Oct; 24(10):1026-35. PMID: 26251229.
    Citations: 2     Fields:    Translation:Humans
  53. Cohen JP, Dong J, Lu CY, Chakravarthy R. Restricting access to florbetapir: Medicare coverage criteria for diagnostics and drugs are inconsistent. BMJ. 2015 Jul 03; 351:h3333. PMID: 26141315.
    Citations:    Fields:    Translation:Humans
  54. Hsu JC, Ross-Degnan D, Wagner AK, Zhang F, Lu CY. How Did Multiple FDA Actions Affect the Utilization and Reimbursed Costs of Thiazolidinediones in US Medicaid? Clin Ther. 2015 Jul 01; 37(7):1420-1432.e1. PMID: 25976425.
    Citations: 2     Fields:    Translation:Humans
  55. Ahmedani BK, Stewart C, Simon GE, Lynch F, Lu CY, Waitzfelder BE, Solberg LI, Owen-Smith AA, Beck A, Copeland LA, Hunkeler EM, Rossom RC, Williams K. Racial/Ethnic differences in health care visits made before suicide attempt across the United States. Med Care. 2015 May; 53(5):430-5. PMID: 25872151.
    Citations: 9     Fields:    Translation:Humans
  56. Lu CY, Zhang F, Lakoma MD, Butler MG, Fung V, Larkin EK, Kharbanda EO, Vollmer WM, Lieu T, Soumerai SB, Chen Wu A. Asthma Treatments and Mental Health Visits After a Food and Drug Administration Label Change for Leukotriene Inhibitors. Clin Ther. 2015 Jun 01; 37(6):1280-91. PMID: 25920571.
    Citations:    
  57. Hsu JC, Ross-Degnan D, Wagner AK, Cheng CL, Yang YH, Zhang F, Lu CY. Utilization of oral antidiabetic medications in Taiwan following strategies to promote access to medicines for chronic diseases in community pharmacies. J Pharm Policy Pract. 2015; 8(1):15. PMID: 25949816.
    Citations: 1     
  58. Hsu JC, Hsieh CY, Yang YH, Lu CY. Net clinical benefit of oral anticoagulants: a multiple criteria decision analysis. PLoS One. 2015; 10(4):e0124806. PMID: 25897861.
    Citations: 5     Fields:    Translation:Humans
  59. Lu CY, Cohen JP. Can genomic medicine improve financial sustainability of health systems? Mol Diagn Ther. 2015 Apr; 19(2):71-7. PMID: 25862552.
    Citations: 1     Fields:    Translation:Humans
  60. Lu CY. Pharmacy Practice Research Methods (Babar Z, editor). Pharmacoepidemiological Approaches in Health Care. 2015.
  61. Sruamsiri R, Ross-Degnan D, Lu CY, Chaiyakunapruk N, Wagner AK. Policies and programs to facilitate access to targeted cancer therapies in Thailand. PLoS One. 2015; 10(3):e0119945. PMID: 25798948.
    Citations: 3     Fields:    Translation:Humans
  62. Lu CY, Emmerick IC, Stephens P, Ross-Degnan D, Wagner AK. Uptake of new antidiabetic medications in three emerging markets: a comparison between Brazil, China and Thailand. J Pharm Policy Pract. 2015; 8(1):7. PMID: 25815201.
    Citations: 1     
  63. Lu CY, Lupton C, Rakowsky S, Babar ZU, Ross-Degnan D, Wagner AK. Patient access schemes in Asia-pacific markets: current experience and future potential. J Pharm Policy Pract. 2015; 8(1):6. PMID: 25815200.
    Citations: 5     
  64. Hsu JC, Lu CY. The evolution of Taiwan's National Health Insurance drug reimbursement scheme. Daru. 2015 Feb 10; 23:15. PMID: 25889754.
    Citations: 4     Fields:    Translation:Humans
  65. Lu CY. Pharmaceutical Prices in the 21st Century (Babar Z, editor). The Pharmaceutical Policy Environment and Pharmaceutical Pricing Policies. 2015.
  66. Kelly E, Lu CY, Albertini S, Vitry A. Longitudinal trends in utilization of endocrine therapies for breast cancer: an international comparison. J Clin Pharm Ther. 2015 Feb; 40(1):76-82. PMID: 25367863.
    Citations: 4     Fields:    Translation:Humans
  67. Ahmedani BK, Solberg LI, Copeland LA, Fang-Hollingsworth Y, Stewart C, Hu J, Nerenz DR, Williams LK, Cassidy-Bushrow AE, Waxmonsky J, Lu CY, Waitzfelder BE, Owen-Smith AA, Coleman KJ, Lynch FL, Ahmed AT, Beck A, Rossom RC, Simon GE. Psychiatric comorbidity and 30-day readmissions after hospitalization for heart failure, AMI, and pneumonia. Psychiatr Serv. 2015 Feb 01; 66(2):134-40. PMID: 25642610.
    Citations: 13     Fields:    Translation:Humans
  68. Lu CY, Simon G, Soumerai SB. Authors' reply to Mosholder and colleagues. BMJ. 2014 Oct 29; 349:g6516. PMID: 25354502.
    Citations:    Fields:    Translation:Humans
  69. Hsu JC, Tang DH, Lu CY. Risk-benefit assessment of oral phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction: a multiple criteria decision analysis. Int J Clin Pract. 2015 Apr; 69(4):436-43. PMID: 25311239.
    Citations: 2     Fields:    Translation:Humans
  70. Lu CY, Simon G, Soumerai SB. Authors' reply to Olfson and Schoenbaum, Nardo, Bartlett, Moore, Case, Gøtzsche, and Barber and colleagues. BMJ. 2014 Oct 09; 349:g5722. PMID: 25301799.
    Citations:    Fields:    Translation:Humans
  71. Lu CY. Uncertainties in real-world decisions on medical technologies. Int J Clin Pract. 2014 Aug; 68(8):936-40. PMID: 25074335.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  72. Lu CY, Zhang F, Lakoma MD, Madden JM, Rusinak D, Penfold RB, Simon G, Ahmedani BK, Clarke G, Hunkeler EM, Waitzfelder B, Owen-Smith A, Raebel MA, Rossom R, Coleman KJ, Copeland LA, Soumerai SB. Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study. BMJ. 2014 Jun 18; 348:g3596. PMID: 24942789.
    Citations: 29     Fields:    Translation:Humans
  73. Lu CY, Stewart C, Ahmed AT, Ahmedani BK, Coleman K, Copeland LA, Hunkeler EM, Lakoma MD, Madden JM, Penfold RB, Rusinak D, Zhang F, Soumerai SB. How complete are E-codes in commercial plan claims databases? Pharmacoepidemiol Drug Saf. 2014 Feb; 23(2):218-20. PMID: 24453020.
    Citations: 7     Fields:    Translation:Humans
  74. Penfold RB, Stewart C, Hunkeler EM, Madden JM, Cummings JR, Owen-Smith AA, Rossom RC, Lu CY, Lynch FL, Waitzfelder BE, Coleman KJ, Coleman KA, Ahmedani BK, Beck AL, Zeber JE, Simon GE. Use of antipsychotic medications in pediatric populations: what do the data say? Curr Psychiatry Rep. 2013 Dec; 15(12):426. PMID: 24258527.
    Citations: 17     Fields:    Translation:Humans
  75. Hsu JC, Lu CY, Wagner AK, Chan KA, Lai MS, Ross-Degnan D. Impacts of drug reimbursement reductions on utilization and expenditures of oral antidiabetic medications in Taiwan: an interrupted time series study. Health Policy. 2014 Jun; 116(2-3):196-205. PMID: 24314624.
    Citations: 5     Fields:    Translation:Humans
  76. Lu CY, Srasuebkul P, Drew AK, Chen K, Ward RL, Pearson SA. Trastuzumab therapy in Australia: which patients with HER2+ metastatic breast cancer are assessed for cardiac function? Breast. 2013 Aug; 22(4):482-7. PMID: 23664254.
    Citations: 5     Fields:    Translation:Humans
  77. Lu CY, Ross-Degnan D, Stephens P, Liu B, Wagner AK. Changes in use of antidiabetic medications following price regulations in China (1999–2009). Journal of Pharmaceutical Health Services Research. 2013; 4(1):3-11.
  78. Lu CY, Srasuebkul P, Drew AK, Ward RL, Pearson SA. Positive spillover effects of prescribing requirements: increased cardiac testing in patients treated with trastuzumab for HER2+ metastatic breast cancer. Intern Med J. 2012 Nov; 42(11):1229-35. PMID: 21981464.
    Citations: 4     Fields:    Translation:Humans
  79. Stavrou EP, Lu CY, Buckley N, Pearson S. The role of comorbidities on the uptake of systemic treatment and 3-year survival in older cancer patients. Ann Oncol. 2012 Sep; 23(9):2422-8. PMID: 22351742.
    Citations: 4     Fields:    Translation:Humans
  80. Lu VH, Lu CY, Goldberg I. Taking on glaucoma care as an interprofessional team. Can J Ophthalmol. 2011 Dec; 46(6):465-7. PMID: 22153630.
    Citations:    Fields:    Translation:Humans
  81. Lu CY, Karnon J, Sorich MJ. The importance of high-quality evidence of the long-term impact of nonfatal events used in randomized controlled trials: a case study of prasugrel. Clin Pharmacol Ther. 2011 Jul; 90(1):27-9. PMID: 21691272.
    Citations: 1     Fields:    Translation:Humans
  82. Lu CY, Roughead E. New users of antidepressant medications: first episode duration and predictors of discontinuation. Eur J Clin Pharmacol. 2012 Jan; 68(1):65-71. PMID: 21713518.
    Citations: 8     Fields:    Translation:Humans
  83. Lu CY, Roughead E. Determinants of patient-reported medication errors: a comparison among seven countries. Int J Clin Pract. 2011 Jul; 65(7):733-40. PMID: 21470350.
    Citations: 7     Fields:    Translation:Humans
  84. Vitry AI, Thai LP, Lu CY. Time and geographical variations in utilization of endocrine therapy for breast cancer in Australia. Intern Med J. 2011 Feb; 41(2):162-6. PMID: 20646097.
    Citations: 3     Fields:    Translation:Humans
  85. Lu CY, Adams AS, Ross-Degnan D, Zhang F, Zhang Y, Salzman C, Soumerai SB. Association between prior authorization for medications and health service use by Medicaid patients with bipolar disorder. Psychiatr Serv. 2011 Feb; 62(2):186-93. PMID: 21285097.
    Citations: 9     Fields:    Translation:Humans
  86. Lu CY, Law MR, Soumerai SB, Graves AJ, LeCates RF, Zhang F, Ross-Degnan D, Adams AS. Impact of prior authorization on the use and costs of lipid-lowering medications among Michigan and Indiana dual enrollees in Medicaid and Medicare: results of a longitudinal, population-based study. Clin Ther. 2011 Jan; 33(1):135-44. PMID: 21397779.
    Citations: 6     Fields:    Translation:Humans
  87. Lu CY, Lu VH, Goldberg I, Day RO. Towards integrated care: Australia's new model of care for patients with glaucoma. Med J Aust. 2010 Aug 16; 193(4):200-1. PMID: 20712538.
    Citations: 1     Fields:    Translation:Humans
  88. Lu VH, Goldberg I, Lu CY. Use of glaucoma medications: state of the science and directions for observational research. Am J Ophthalmol. 2010 Oct; 150(4):569-574.e9. PMID: 20678750.
    Citations: 11     Fields:    Translation:Humans
  89. Lu CY, Barratt J, Vitry A, Roughead E. Charlson and Rx-Risk comorbidity indices were predictive of mortality in the Australian health care setting. J Clin Epidemiol. 2011 Feb; 64(2):223-8. PMID: 21172602.
    Citations: 14     Fields:    Translation:Humans
  90. Law MR, Lu CY, Soumerai SB, Graves AJ, LeCates RF, Zhang F, Ross-Degnan D, Adams AS. Impact of two Medicaid prior-authorization policies on antihypertensive use and costs among Michigan and Indiana residents dually enrolled in Medicaid and Medicare: results of a longitudinal, population-based study. Clin Ther. 2010 Apr; 32(4):729-41; discussion 716. PMID: 20435243.
    Citations: 5     Fields:    Translation:Humans
  91. Lu CY, Soumerai SB, Ross-Degnan D, Zhang F, Adams AS. Unintended impacts of a Medicaid prior authorization policy on access to medications for bipolar illness. Med Care. 2010 Jan; 48(1):4-9. PMID: 19956079.
    Citations: 17     Fields:    Translation:Humans
  92. Lu CY. Observational studies: a review of study designs, challenges and strategies to reduce confounding. Int J Clin Pract. 2009 May; 63(5):691-7. PMID: 19392919.
    Citations: 8     Fields:    
  93. Lu CY. Pharmacoepidemiologic research in Australia: challenges and opportunities for monitoring patients with rheumatic diseases. Clin Rheumatol. 2009 Apr; 28(4):371-7. PMID: 19190976.
    Citations:    Fields:    Translation:Humans
  94. Lu CY, Macneill P, Williams K, Day R. Access to high cost medicines in Australia: ethical perspectives. Aust New Zealand Health Policy. 2008 May 19; 5:4. PMID: 18489760.
    Citations: 3     
  95. Chung Y, Lu CY, Graham GG, Mant A, Day RO. Utilization of allopurinol in the Australian community. Intern Med J. 2008 Jun; 38(6):388-95. PMID: 18422564.
    Citations: 3     Fields:    Translation:Humans
  96. Lu CY, Ross-Degnan D, Soumerai SB, Pearson SA. Interventions designed to improve the quality and efficiency of medication use in managed care: a critical review of the literature - 2001-2007. BMC Health Serv Res. 2008 Apr 07; 8:75. PMID: 18394200.
    Citations: 29     Fields:    Translation:Humans
  97. Lu CY, Ritchie J, Williams K, Day R. The views of stakeholders on controlled access schemes for high-cost antirheumatic biological medicines in Australia. Aust New Zealand Health Policy. 2007 Dec 20; 4:26. PMID: 18096055.
    Citations: 2     
  98. Lu CY, Williams KM, Day RO. Has the use of disease-modifying anti-rheumatic drugs changed as a consequence of controlled access to high-cost biological agents through the Pharmaceutical Benefits Scheme? Intern Med J. 2007 Sep; 37(9):601-6. PMID: 17542999.
    Citations: 2     Fields:    Translation:Humans
  99. Lu CY, Williams KM, Day RO. The funding and use of high-cost medicines in Australia: the example of anti-rheumatic biological medicines. Aust New Zealand Health Policy. 2007 Mar 01; 4:2. PMID: 17331230.
    Citations: 8     
  100. Lu CY, Williams KM, Day RO. Accessing health outcome data on high-cost medicines in Australia. Med J Aust. 2006 Apr 17; 184(8):411-3. PMID: 16618242.
    Citations: 3     Fields:    Translation:Humans
  101. Lu CY, Williams KM, Day RO. Access to tumour necrosis factor inhibitors for rheumatoid arthritis treatment under the Australian Pharmaceutical Benefits Scheme: are we on target? Intern Med J. 2006 Jan; 36(1):19-27. PMID: 16409309.
    Citations: 4     Fields:    Translation:Humans
  102. Lu CY, Ritchie J, Williams KM, Day RO. Recent developments in targeting access to high cost medicines in Australia. Aust New Zealand Health Policy. 2005 Nov 23; 2:28. PMID: 16305742.
    Citations: 2     
  103. Hall WD, Ward R, Liauw WS, Lu CY, Brien JA. Tailoring access to high cost, genetically targeted drugs. Med J Aust. 2005 Jun 20; 182(12):607-8. PMID: 15963014.
    Citations: 5     Fields:    Translation:Humans
  104. Lu CY, Williams KM, March L, Bertouch JV, Day RO. Subsidised access to TNF alpha inhibitors: is the rationale for exclusion of rheumatoid-factor-negative patients defensible? Med J Aust. 2004 Oct 18; 181(8):457; discussion 457-8. PMID: 15487967.
    Citations: 4     Fields:    Translation:Humans
  105. Lu CY, Williams K, Day R, March L, Sansom L, Bertouch J. Access to high cost drugs in Australia. BMJ. 2004 Aug 21; 329(7463):415-6. PMID: 15321884.
    Citations: 9     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Lu's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (343)
Explore
_
Co-Authors (29)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.